Symptoms
Vaginal dryness in menopause
NICE groups vulvovaginal dryness, discomfort, pain with sex and pain when you pee as genitourinary symptoms of menopause. It recommends vaginal oestrogen for those symptoms, including for people already using a patch, gel or other systemic HRT.

What genitourinary syndrome of menopause feels like
The NHS menopause symptoms page describes a burning feeling, irritation or itching in and around the vagina, along with dryness. Sex can feel painful. The page notes that these symptoms can continue after menopause.
The same NHS page lists more urinary tract infections, or symptoms that feel like one: pain or a burning sensation when you pee, and needing to pee more often than usual, including at night.
NICE Clinical Knowledge Summaries use genitourinary syndrome of menopause for this cluster. The features they name include dryness, pain during sex, a lower libido, pain when passing urine, urinary frequency and urgency, and repeated lower urinary tract infections.
Vaginal atrophy is the tissue change behind that cluster. CKS prescribing notes use urogenital atrophy for the same change when vaginal or bladder symptoms are the main problem.
CKS says these genitourinary symptoms can impair health, sexual function and quality of life, and that they are likely underdiagnosed and undertreated.
Other changes in these years are gathered on the menopause symptoms topic hub.
Moisturisers and lubricants
The NHS self-help page includes moisturisers and lubricants you can buy at a pharmacy, and hormonal treatment a GP can prescribe.
NICE NG23 names non-hormonal moisturisers or lubricants for people who cannot use vaginal oestrogen, or who decline it. The same recommendations allow the local hormone on its own or together with those non-hormonal products.
How vaginal oestrogen differs from HRT for flushes
This preparation stays local. The NHS page on vaginal oestrogen says it is for menopausal dryness and irritation, and that it will not treat hot flushes, mood swings or problems sleeping.
Which product you use is a shared decision. NICE lists a cream, a gel, a tablet, a pessary or a ring.
Little of the medicine reaches the rest of the body. That NHS page says this is why you do not need a progestogen with it. NHS guidance on types of HRT says you can use this treatment without a progestogen even if you still have a womb. CKS prescribing information gives the same reason: absorption into the bloodstream is minimal, so a progestogen for womb protection is not added.
When this treatment is offered, NICE asks clinicians to explain that serious adverse effects are very rare, that only a minimal amount enters the bloodstream compared with systemic HRT, and that this amount is unlikely to have a significant effect throughout the body.
The NHS benefits and risks page states that this local hormone helps with dryness and does not increase the risk of breast cancer, blood clots or other conditions. The common-questions page describes lower breast cancer and blood clot risks than for other types of HRT. The guide to HRT risks in plain numbers sets out extra cases per 1,000 women for tablets, patches and combined HRT. Those counts belong to systemic treatment.
Where vaginal or bladder symptoms of urogenital atrophy predominate, CKS allows the vaginal preparation on its own.
Already on a patch or gel
The NICE offer of vaginal oestrogen explicitly includes people who are already using systemic HRT. CKS recommends a low dose for that same group. Dryness or soreness that continues is a reason to raise local treatment at the next review.
What a systemic prescription contains, including a progestogen when you have a womb, is in the guide to hormone replacement therapy for menopause. Related guides sit on the HRT topic hub.
Painful sex after menopause
Pain during sex is one of the genitourinary symptoms listed above. CKS uses the clinical word dyspareunia. Dryness and soreness need treatment before a prescription for low sex drive is considered.
Testosterone for low sex drive is the guide for low desire once those local symptoms have been addressed. NICE considers testosterone when HRT alone has not helped desire.
See a GP if dryness has lasted for weeks and self-care has not helped, if it affects daily life, or if there is unusual discharge or bleeding after menopause (NHS: vaginal dryness).
Menopause bladder symptoms and repeated infections
Burning when you pee, and needing to go more often at night, are the urinary symptoms on the NHS menopause page cited above.
For infections that keep returning, the NHS urinary tract infection page says a GP may prescribe a vaginal cream, gel, tablet, pessary or ring containing oestrogen if you are in perimenopause or have gone through menopause.
CKS guidance for GPs includes topical vaginal oestrogen, marked off-label, in its notes on repeated urinary infections. The note covers women in perimenopause or after menopause when self-care has not worked, and it asks the GP to talk about dryness in that conversation.
How long local treatment takes
On the NHS common-questions page, a full effect can take up to three months. If you are not better after three months, speak to a doctor.
NICE places the first review at that point, then once a year, unless a problem needs an earlier visit. The recommendation also says symptoms often return when the treatment is stopped, and that it can be restarted if you need it again.
People writing on menopause forums describe waiting from a few weeks to several months before dryness improves. The posts are personal reports, and the follow-up to agree with a clinician is the review interval above.
Flushes and the early months on a patch or gel have their own timeframe, set out in how long systemic HRT takes to work. How long that systemic treatment can continue, and how a later stop is planned, is in how long you can stay on HRT.
A history of breast cancer
For someone with a personal history of breast cancer and these genitourinary symptoms, NICE says to offer non-hormonal moisturisers or lubricants first. That is recommendation 1.5.14.
If the symptoms continue after those non-hormonal treatments, recommendation 1.5.15 brings vaginal oestrogen into the conversation. People receiving an adjuvant aromatase inhibitor are pointed to recommendation 1.5.16, which brings in a breast cancer specialist.
The NHS line that vaginal oestrogen does not increase breast cancer or clot risk is the general statement in the section above. Figures for breast cancer with systemic HRT, in extra cases per 1,000 women, stay on the risks page already linked. They are counted for that systemic treatment.
What to ask at the appointment
If you want a paper record for the visit, the menopause symptom checklist for your GP logs how often each symptom happens.
Ask which formulation fits the symptoms you have. Ask whether local oestrogen should sit alongside HRT you already take. Ask for the review date, using the interval in the section above.
How to start HRT covers a first visit about systemic HRT, when hot flushes or several symptoms together are the reason for going.
My take
I would start with a moisturiser and local oestrogen if dryness or painful sex is the reason for the visit and flushes are mild. When flushes need treating as well, I would ask for a patch or gel and for this local treatment to be discussed in the same visit. I would want the review date written down before leaving.
Sources
- NICE NG23 recommendations
- NICE CKS: menopause clinical features
- NICE CKS: menopause prevalence
- NICE CKS: managing menopause
- NICE CKS: HRT prescribing information
- NICE CKS: recurrent UTI in women
- NHS: menopause symptoms
- NHS: things you can do
- NHS: about vaginal oestrogen
- NHS: common questions about vaginal oestrogen
- NHS: types of HRT
- NHS: benefits and risks of HRT
- NHS: urinary tract infections
- NHS: vaginal dryness